O

OncoLens

17 employees

OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

Basic info

Industry

health, wellness & fitness

Sectors

Prostate Cancer
NAPBC
Director
Tumor Boards
Healthcare Technology
Accreditation Assistance
Cancer Conferences
Oncology Services
Trial Management Software
Hematology
Health Care
Oncology
Cancer Research
Breast Cancer
Multidisciplinary Cancer Care
Clinical Trials
Information Technology
Lung Cancer
Colon Cancer
Molecular Tumor Board
Cancer Registrars
Commission on Cancer
Medical

Date founded

2016

Funding rounds raised

Total raised

$7.3M

from 9 investors over 9 rounds

O

OncoLens raised undisclosed on July 13, 2023

Investors: Cross-Border Impact Ventures

O

OncoLens raised $7.3M on January 14, 2021

Investors: BIP CAPITAL and SeedtoB Capital

O

OncoLens raised $2.5M on January 6, 2020

Investors: BIP CAPITAL and Atlanta Technology Angels

O

OncoLens raised $1.4M on March 26, 2019

Investors: BIP CAPITAL and Atlanta Technology Angels

O

OncoLens raised $750K on February 14, 2019

Investors: BIP CAPITAL and Atlanta Technology Angels

FAQ